Critical Insight into the Attributes of Emerging Novel Coronavirus (COVID-19) in India and Across the World

Author(s): Gaurav M. Doshi*, Hemen S. Ved, Ami P. Thakkar

Journal Name: Coronaviruses
The World's First International Journal Dedicated to Coronaviruses

Volume 1 , Issue 1 , 2020


Become EABM
Become Reviewer
Call for Editor

Abstract:

The World Health Organization (WHO) has recently announced the spread of novel coronavirus (nCoV) globally and has declared it a pandemic. The probable source of transmission of the virus, which is from animal to human and human to human contact, has been established. As per the statistics reported by the WHO on 11th April 2020, data has shown that more than sixteen lakh confirmed cases have been identified globally. The reported cases related to nCoV in India have been rising substantially. The review article discusses the characteristics of nCoV in detail with the probability of potentially effective old drugs that may inhibit the virus. The research may further emphasize and draw the attention of the world towards the development of an effective vaccine as well as alternative therapies. Moreover, the article will help to bridge the gap between the new researchers since it’s the current thrust area of research.

Keywords: Novel coronavirus, SARS-CoV-2, nCoV, COVID-19, global impact, signs, symptoms.

[1]
Schoeman D, Fielding BC. Coronavirus envelope protein: Current knowledge. Virology Journal 2019; 16: 1-22.
[2]
Zhu Y, Li C, Chen L, et al. A novel human coronavirus OC43 genotype detected in mainland China. Emerg Microbes Infect 2018; 7(1): 173.
[http://dx.doi.org/10.1038/s41426-018-0171-5] [PMID: 30377292]
[3]
Zimmermann P, Curtis N. Coronavirus infections in children including COVID-19: An overview of the epidemiology, clinical features, diagnosis, treatment and prevention options in children. Pediatr Infect Dis J 2020; 39(5): 355-68.
[http://dx.doi.org/10.1097/INF.0000000000002660] [PMID: 32310621]
[4]
What is coronavirus: Symptoms, how it spreads, how to avoid it - The Washington Post https://www.washingtonpost.com/health/2020/02/28/what-you-need-know-about-coronavirus/?arc404=true
[5]
Cyranoski D. Mystery deepens over animal source of coronavirus. Nature 2020; 579(7797): 18-9.
[http://dx.doi.org/10.1038/d41586-020-00548-w] [PMID: 32127703]
[6]
Liu P, Jiang J-Z, Hua Y, et al. Are pangolins the intermediate host of the 2019 novel coronavirus (2019-nCoV)? bioRxiv 2020.
[8]
Sohrabi C, Alsafi Z, O’Neill N, et al. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). Int J Surg 2020; 76: 71-6.
[http://dx.doi.org/10.1016/j.ijsu.2020.02.034] [PMID: 32112977]
[9]
Han W, Quan B, Guo Y, et al. The course of clinical diagnosis and treatment of a case infected with coronavirus disease. J Med Virol 2020; 0-1.
[10]
Coronavirus outbreak: Top coronavirus drugs and vaccines in development https://www.clinicaltrialsarena.com/analysis/coronavirus-mers-cov-drugs/
[11]
Hayden FG, Shindo N. Influenza virus polymerase inhibitors in clinical development. Curr Opin Infect Dis 2019; 32(2): 176-86.
[http://dx.doi.org/10.1097/QCO.0000000000000532] [PMID: 30724789]
[13]
She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med 2020; 9(1): 19.
[http://dx.doi.org/10.1186/s40169-020-00271-z] [PMID: 32078069]
[14]
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 8(5): 475-81.
[http://dx.doi.org/10.1016/S2213-2600(20)30079-5] [PMID: 32105632]
[15]
Young BE, Ong SWX, Kalimuddin S, et al. Singapore 2019 novel coronavirus outbreak research team. epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore. JAMA 2020; 323: 1488-94.
[http://dx.doi.org/10.1001/jama.2020.3204] [PMID: 32125362]
[17]
USDA APHIS | USDA Statement on the Confirmation of COVID- 19 in a Tiger in New York https://www.aphis.usda.gov/aphis/newsroom/news/sa_by_date/sa-2020/ny-zoo-covid-19
[18]
Report of the WHO-China Joint Mission on Coronavirus Disease 2019 ( COVID-19 ) 2020; 16-24.
[19]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[20]
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395(10223): 507-13.
[http://dx.doi.org/10.1016/S0140-6736(20)30211-7] [PMID: 32007143]
[22]
Wang Y, Wang Y, Chen Y, et al. Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures. J Med Virol 2020; 0-1.
[23]
Wang XF, Yuan J, Zheng YJ, et al. Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen Zhonghua er ke za zhi = Chinese. J Pediatr 2020; 58, E008
[PMID: 32062875]
[24]
Xia Y, Jin R, Zhao J, et al. Risk of COVID-19 for cancer patients. Lancet Oncol 2020; 21, e180
[http://dx.doi.org/10.1016/S1470-2045(20)30150-9]
[25]
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA 2020; 17: 1061-9.
[26]
Zhang J, Wu J, Sun X, et al. Associations of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis. Epidemiol Infect 2020; 148.
[http://dx.doi.org/10.1017/S095026882000117X]
[27]
Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. Am J Hypertens 2020; 33(5): 373-4.
[http://dx.doi.org/10.1093/ajh/hpaa057] [PMID: 32251498]
[28]
Tal S, Spectre G, Kornowski R, Perl L. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far? Acta Haematol 2020; 49100: 1-8.
[http://dx.doi.org/10.1159/000508233] [PMID: 32396903]
[29]
Wise J. Covid-19 and thrombosis: what do we know about the risks and treatment? BMJ 2020; 369: 2058.
[http://dx.doi.org/10.1136/bmj.m2058] [PMID: 32439704]
[30]
Li X, Ma X. Acute respiratory failure in COVID-19: is it “typical” ARDS? Crit Care 2020; 24(1): 198.
[http://dx.doi.org/10.1186/s13054-020-02911-9] [PMID: 32375845]
[31]
De Biase S, Cook L, Skelton DA, Witham M, Ten Hove R. The COVID-19 Rehabilitation Pandemic. Age Ageing 2020.
[PMID: 32470131]
[32]
Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol 2020; 92(4): 401-2.
[http://dx.doi.org/10.1002/jmv.25678] [PMID: 31950516]
[33]
Lai C-C, Shih T-P, Ko W-C, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020; 55(3) 105924
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105924] [PMID: 32081636]
[34]
COVID-19 map: Tracking the coronavirus outbreak worldwide https://infographics.channelnewsasia.com/covid-19/map.html
[35]
Countries where Coronavirus has spread - Worldometer https://www.worldometers.info/coronavirus/countries-where-coronavirus-has-spread/
[37]
One COVID-19 positive infects 1.7 in India, lower than in hot zones coronavirus outbreak News The Indian Express https://indianexpress.com/article/coronavirus/coronavirus-india-infection-rate-china-6321154/
[38]
India coronavirus: Millions under lockdown as major cities restrict daily life - CNN https://edition.cnn.com/2020/03/23/asia/coronavirus-covid-19-update-india-intl-hnk/index.html
[39]
Indian Council of Medical Research | Government of India https://main.icmr.nic.in/
[40]
India to set up lab in Iran to test citizens for coronavirus before evacuation - india news - Hindustan Times https://www.hindustantimes.com/india-news/india-to-set-up-lab-in-iran-to-test-citizens-for-coronavirus-before-evacuation/story-Bz9PUrtkaLGUFNzEBbQEPJ.html
[41]
[42]
India suspends most visas to halt coronavirus spread - BBC News https://www.bbc.com/news/world-asia-india-51847620
[43]
Home | Ministry of Health and Family Welfare | GOI https://www.mohfw.gov.in/
[44]
[45]
India readies list of 13 countries to send hydroxychloroquine - Express Pharma https://www.expresspharma.in/covid19-updates/india-readies-list-of-13-countries-to-send-hydroxychloroquine/
[46]
Wan Y, Shang J, Graham R, Baric RS, Li F. Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS. J Virol 2020; 94(7): e00127-20.
[http://dx.doi.org/10.1128/JVI.00127-20] [PMID: 31996437]
[47]
Demogines A, Farzan M, Sawyer SL. Evidence for ACE2-utilizing coronaviruses (CoVs) related to severe acute respiratory syndrome CoV in bats. J Virol 2012; 86(11): 6350-3.
[http://dx.doi.org/10.1128/JVI.00311-12] [PMID: 22438550]
[48]
Liu Z, Xiao X, Wei X, et al. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. J Med Virol 2020; 92: 595-601.
[http://dx.doi.org/10.1002/jmv.25726]
[50]
Zhang L, Liu Y. Potential interventions for novel coronavirus in China: A systematic review. J Med Virol 2020; 92(5): 479-90.
[http://dx.doi.org/10.1002/jmv.25707] [PMID: 32052466]
[51]
Hopes rise over experimental drug’s effectiveness against coronavirus | World news | The Guardian https://www.theguardian. com/world/2020/mar/10/hopes-rise-over-experimental-drugs-effectiveness-against-coronavirus
[52]
Remdesivir could be a potential treatment of Covid-19 https://www.clinicaltrialsarena.com/projects/remdesivir/
[53]
Colson P, Rolain J-M, Lagier J-C, Brouqui P, Raoult D. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19. Int J Antimicrob Agents 2020; 55(4) 105932
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105932] [PMID: 32145363]
[54]
Touret F, de Lamballerie X. Of chloroquine and COVID-19. Antiviral Res 2020; 177, 104762
[http://dx.doi.org/10.1016/j.antiviral.2020.104762] [PMID: 32147496]
[55]
Gao J, Tian Z, Yang X. Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends 2020; 14(1): 72-3.
[http://dx.doi.org/10.5582/bst.2020.01047] [PMID: 32074550]
[56]
] Evaluating and comparing the safety and efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for novel Coronavirus infection https://clinicaltrials.gov/ct2/show/NCT04261907
[57]
Harrison C. Coronavirus puts drug repurposing on the fast track. Nat Biotechnol 2020; 38(4): 379-81.
[http://dx.doi.org/10.1038/d41587-020-00003-1] [PMID: 32205870]
[58]
Haviernik J, Štefánik M, Fojtíková M, et al. Arbidol (Umifenovir): A broad-spectrum antiviral drug that inhibits medically important arthropod-borne flaviviruses. Viruses 2018; 10: 184.
[59]
Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci Trends 2020; 14: 69-71.
[60]
Bleibtreu A, Jaureguiberry S, Houhou N, et al. Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016. BMC Infect Dis 2018; 18(1): 331.
[http://dx.doi.org/10.1186/s12879-018-3223-5] [PMID: 30012113]
[61]
Zhai P, Ding Y, Wu X, Long J, Zhong Y, Li Y. The epidemiology, diagnosis and treatment of COVID-19. Int J Antimicrob Agents 2020; 55(5): 105955-5.
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105955] [PMID: 32234468]
[62]
Lou Y, Liu L, Qiu Y. Clinical outcomes and plasma concentrations of Baloxavir Marboxil and Favipiravir in COVID-19 patients: an exploratory randomized, controlled trial. medRxiv 2020.
[63]
Chinese Clinical Trial Register (ChiCTR) - The world health organization international clinical trials registered organization registered platform http://www.chictr.org.cn/showprojen.aspx?proj=49015
[64]
Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 2020; 46(4): 586-90.
[http://dx.doi.org/10.1007/s00134-020-05985-9] [PMID: 32125455]
[65]
Chinese Clinical Trial Register (ChiCTR) - The world health organization international clinical trials registered organization registered platform http://www.chictr.org.cn/showprojen.aspx?proj=48992
[66]
Immunoregulatory Therapy for 2019-nCoV - Full Text View - ClinicalTrialsgov 2019.https://clinicaltrials.gov/ct2/show/NCT04268537
[67]
Thanh Le T, Andreadakis Z, Kumar A, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov 2020; 19(5): 305-6.
[http://dx.doi.org/10.1038/d41573-020-00073-5] [PMID: 32273591]
[68]
Shih HI, Wu CJ, Tu YF, Chi CY. Fighting COVID-19: A quick review of diagnoses, therapies, and vaccines. Biomed J 2020.S2319- 4170(20): 30085-8.
[http://dx.doi.org/10.1016/j.bj.2020.05.021] [PMID: 32532623]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 1
ISSUE: 1
Year: 2020
Page: [49 - 56]
Pages: 8
DOI: 10.2174/2666796701999200623172631

Article Metrics

PDF: 19
HTML: 1